A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz-Based Regimens
© 2016, The American College of Clinical Pharmacology Efavirenz use is associated with changes in cholesterol concentrations, but it is unclear whether this effect is related to drug concentrations. Using efavirenz and cholesterol plasma concentrations measured in 87 antiretroviral-naive children in...
Saved in:
Main Authors: | Nontiya Homkham, Tim R. Cressey, Lily Ingsrisawang, Naïm Bouazza, Chaiwat Ngampiyaskul, Suchat Hongsiriwon, Sakulrat Srirojana, Suparat Kanjanavanit, Sorakij Bhakeecheep, Sophie Le Coeur, Nicolas Salvadori, Jean Marc Treluyer, Gonzague Jourdain, Saik Urien |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84959423363&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/56250 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz-Based Regimens
by: Homkham N., et al.
Published: (2017) -
Efavirenz concentrations and probability of HIV replication in children
by: Nontiya Homkham, et al.
Published: (2018) -
Efavirenz concentrations and probability of HIV replication in children
by: Nontiya Homkham, et al.
Published: (2018) -
Role of efavirenz plasma concentrations on long-term HIV suppression and immune restoration in HIV-infected children
by: Nontiya Homkham, et al.
Published: (2019) -
Impact of antiretroviral treatment on height evolution of HIV infected children
by: Patrinee Traisathit, et al.
Published: (2019)